Chargement en cours...
Repurposing existing drugs for COVID-19: an endocrinology perspective
BACKGROUND: Coronavirus Disease 2019 (COVID-19) is a multi-systemic infection caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), that has become a pandemic. Although its prevailing symptoms include anosmia, ageusia, dry couch, fever, shortness of brief, arthralgia, mya...
Enregistré dans:
| Publié dans: | BMC Endocr Disord |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7523486/ https://ncbi.nlm.nih.gov/pubmed/32993622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00626-0 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|